Novel molecular pathways in Gorham disease: Implications for treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel molecular pathways in Gorham disease: Implications for treatment

Published:2013-11-08 Issue:3 Volume:61 Page:401-406
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Hagendoorn Jeroen¹,Yock Torunn I.²,Borel Rinkes Inne H.M.¹,Padera Timothy P.³,Ebb David H.⁴

Affiliation:

1. Department of Surgical Oncology; University Medical Center Utrecht; Utrecht The Netherlands

2. Department of Radiation Oncology; Massachusetts General Hospital and Harvard Medical School; Boston Massachusetts

3. Edwin L. Steele Laboratory for Tumor Biology; Massachusetts General Hospital and Harvard Medical School; Boston Massachusetts

4. Department of Pediatric Hematology; Oncology, Massachusetts General Hospital and Harvard Medical School; Boston Massachusetts

Funder

NIH

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.24832/fullpdf

Reference63 articles.

1. Congenital lymphatic malformations;Blei;Ann N Y Acad Sci,2008

2. Gorham's disease or massive osteolysis;Patel;Clin Med Res,2005

3. Chylothorax associated with massive osteolysis (Gorham's syndrome);Fujiu;Ann Thorac Surg,2002

4. Lymphangiogenesis: Molecular mechanisms and future promise;Tammela;Cell,2010

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The molecular mechanism of Gorham syndrome: an update;Frontiers in Immunology;2023-05-05

2. Back to the Future II—A Comprehensive Update on the Rapidly Evolving Field of Lymphatic Imaging and Interventions;Investigative Radiology;2023-04-11

3. Thoracic Gorham-Stout disease masquerading as an ovarian malignancy: a differential diagnosis in non-malignant causes of raised Ca-125 and overview of this rare pathology;BMJ Case Reports;2022-11

4. Difficult Therapeutic Decisions in Gorham-Stout Disease–Case Report and Review of the Literature;International Journal of Environmental Research and Public Health;2022-09-16

5. Daratumumab, Lenalidomide, and Dexamethasone (DRD), an Active Regimen in the Treatment of Immunosuppression-Associated Plasmablastic Lymphoma (PBL) in the Setting of Gorham’s Lymphangiomatosis: Review of the Literature;Case Reports in Hematology;2022-06-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3